Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Registration Form 2005

May 12, 2005

29777_rf_2005-05-12_6f2777eb-89a5-4879-a469-b3f16e9bcd34.zip

Registration Form

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

S-8 1 a05-7809_2s8.htm S-8

As filed with the Securities and Exchange Commission on May , 2005.

Registration No. 333-

*UNITED STATES SECURITIES AND EXCHANGE COMMISSION*

*Washington, D.C. 20549*

*FORM S-8*

*REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933*

*Abbott Laboratories*

(Exact name of registrant as specified in its charter)

Illinois 36-0698440
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
Abbott Laboratories 100 Abbott Park Road Abbott Park, Illinois 60064-6400
(Address of Principal Executive Offices) (Zip Code)

*ABBOTT LABORATORIES 1996 INCENTIVE STOCK PROGRAM*

(Full title of the plan)

*Laura J. Schumacher Abbott Laboratories 100 Abbott Park Road Abbott Park, Illinois 60064-6400*

(Name and address of agent for service)

Telephone number, including area code, of agent for service: *(847) 937-5200*

CALCULATION OF REGISTRATION FEE

| Title of
securities to be registered | Amount
to be registered | Proposed
maximum offering price per share (a) | Proposed
maximum aggregate offering price (a) | Amount
of registration fee (a) |
| --- | --- | --- | --- | --- |
| Common shares (without par value) | 46,868,123 | $48.94 | $2,293,725,939 | $269,972 |

(a) An undetermined number of additional shares may be issued if the antidilution provisions of the plan become operative. The filing fee has been calculated in accordance with Rule 457(c) based on the average of the high and low prices of Registrant’s Common Shares reported on the New York Stock Exchange on May 9, 2005.

SEQ.=1,FOLIO='',FILE='C:\JMS\mschroe\05-7809-2\task436981\7809-2-ba.htm',USER='mschroea',CD='May 12 13:41 2005'

Pursuant to General Instruction E, the contents of Abbott Laboratories 1996 Incentive Stock Program Registration Statement on Form S-8 (File no. 333-09071) are incorporated herein by reference.

Part II. Information Required in the Registration Statement

Item 5. Interests of Named Experts and Counsel

Laura J. Schumacher, Esq., Senior Vice President, Secretary and General Counsel of the Registrant, whose opinion is included herewith as Exhibit 5, beneficially owned as of May 11, 2005, approximately 48,500 Common Shares of the Registrant (this amount includes approximately 4,629 shares held for the benefit of Ms. Schumacher in the Abbott Laboratories Stock Retirement Trust pursuant to the Abbott Laboratories Stock Retirement Plan) and held options to acquire 195,168 Common Shares of which options to purchase 90,405 Common Shares are currently exercisable.

Item 8. Exhibits

See Exhibit Index, which is incorporated herein by reference.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\mschroe\05-7809-2\task436981\7809-2-ba.htm',USER='mschroea',CD='May 12 13:41 2005'

SIGNATURES

THE REGISTRANT. Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in unincorporated Lake County, and State of Illinois, on May 11, 2005.

| ABBOTT
LABORATORIES | |
| --- | --- |
| By: | /s/ Miles D.
White |
| | Miles D. White, |
| | Chairman of the Board and |
| | Chief Executive Officer |

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\mschroe\05-7809-2\task436981\7809-2-ba.htm',USER='mschroea',CD='May 12 13:41 2005'

Each person whose signature appears below constitutes and appoints Miles D. White and Laura Schumacher, Esq., and each of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this registration statement, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

Signature Title Date
Chairman of the Board, May 11, 2005
/s/ Miles D. White Chief Executive Officer,
and
Miles D. White Director
President and Chief
Operating Officer, May 11, 2005
/s/ Richard A. Gonzalez Medical Products Group,
Richard A. Gonzalez and Director
President and Chief
Operating May 11, 2005
/s/ Jeffrey M. Leiden Officer, Pharmaceutical
Products
Jeffrey M. Leiden Group, and Director
Executive Vice President,
Finance and May 11, 2005
/s/ Thomas C. Freyman Chief Financial Officer
(Principal
Thomas C. Freyman Financial Officer)
Vice President and
Controller May 11, 2005
/s/ Greg W. Linder (Principal Accounting
Officer)
Greg W. Linder
/s/ Roxanne S. Austin Director May 11, 2005
Roxanne S. Austin
/s/ William M. Daley Director May 11, 2005
William M. Daley
/s/ H. Laurance Fuller Director May 11, 2005
H. Laurance Fuller

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\mschroe\05-7809-2\task436981\7809-2-ba.htm',USER='mschroea',CD='May 12 13:41 2005'

/s/ Jack M. Greenberg Director May 11, 2005
Jack M. Greenberg
/s/
David A. L. Owen Director May
11, 2005
David
A. L. Owen
/s/Boone Powell Jr. Director May 11, 2005
Boone Powell Jr.
/s/ A. Barry Rand Director May 11, 2005
A. Barry Rand
/s/ W. Ann Reynolds Director May 11, 2005
W. Ann Reynolds
/s/ Roy S. Roberts Director May 11, 2005
Roy S. Roberts
/s/ William D. Smithburg Director May 11, 2005
William D. Smithburg
/s/ John R. Walter Director May 11, 2005
John R. Walter

5

SEQ.=1,FOLIO='5',FILE='C:\JMS\mschroe\05-7809-2\task436981\7809-2-ba.htm',USER='mschroea',CD='May 12 13:41 2005'

EXHIBIT INDEX

Exhibit No. Description
5 Opinion of
Laura J. Schumacher.
23.1 The consent
of counsel, Laura J. Schumacher, is included in her opinion.
23.2 Consent of
Deloitte & Touche LLP.
23.3 Consent of
Deloitte & Touche LLP.
24 Power of
Attorney is included on the signature page.

6

SEQ.=1,FOLIO='6',FILE='C:\JMS\mschroe\05-7809-2\task436981\7809-2-ba.htm',USER='mschroea',CD='May 12 13:41 2005'